Tissue glucocorticoid resistance/hypersensitivity syndromes

Tomoshige Kino, Massimo U. De Martino, Evangelia Charmandari, Marco Mirani, George P. Chrousos

Research output: Contribution to journalArticle

129 Citations (Scopus)

Abstract

Glucocorticoids have a broad array of life-sustaining functions and play an important role in the therapy of many diseases. Thus, changes of tissue sensitivity to glucocorticoids may be associated with and influence the course and treatment of many pathologic states. Such tissue sensitivity changes may present on either side of an optimal range, respectively as glucocorticoid resistance or hypersensitivity, and may be generalized or tissue-specific. Familial/sporadic glucocorticoid resistance syndrome caused by inactivating mutations of the glucocorticoid receptor (GR) gene is a classic monogenic disorder associated with congenital, generalized glucocorticoid insensitivity, while several autoimmune, inflammatory and allergic diseases are often associated with resistance of the inflamed tissues to glucocorticoids. On the other hand, glucocorticoid hypersensitivity has been suggested in visceral obesity-related insulin resistance associated with components of the metabolic syndrome, and in the acquired immunodeficiency syndrome (AIDS) caused by human immunodeficiency virus type-1 (HIV-1) infection. Here, we have reviewed the molecular analyses of five familial and three sporadic cases of the familial/sporadic glucocorticoid resistance syndrome and discussed the possible contribution of newly identified molecules, such as HIV-1 accessory proteins Vpr and Tat, FLICE-associated huge protein (FLASH) and chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII), on the molecular regulation of GR activity, as well as their possible contribution to changes in tissue sensitivity to glucocorticoids in pathologic conditions.

Original languageEnglish
Pages (from-to)457-467
Number of pages11
JournalJournal of Steroid Biochemistry and Molecular Biology
Volume85
Issue number2-5
DOIs
Publication statusPublished - Jun 2003
Externally publishedYes

Fingerprint

Glucocorticoids
Hypersensitivity
Tissue
Glucocorticoid Receptors
COUP Transcription Factor II
HIV-1
vpr Gene Products
tat Gene Products
Viruses
Abdominal Obesity
Virus Diseases
Insulin Resistance
Glucocorticoid Receptor Deficiency
Acquired Immunodeficiency Syndrome
Accessories
Mutation
Therapeutics
Genes
Insulin
Proteins

Keywords

  • Accessory proteins
  • Glucocorticoid
  • HIV-1

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)
  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Endocrinology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Tissue glucocorticoid resistance/hypersensitivity syndromes. / Kino, Tomoshige; De Martino, Massimo U.; Charmandari, Evangelia; Mirani, Marco; Chrousos, George P.

In: Journal of Steroid Biochemistry and Molecular Biology, Vol. 85, No. 2-5, 06.2003, p. 457-467.

Research output: Contribution to journalArticle

Kino, Tomoshige ; De Martino, Massimo U. ; Charmandari, Evangelia ; Mirani, Marco ; Chrousos, George P. / Tissue glucocorticoid resistance/hypersensitivity syndromes. In: Journal of Steroid Biochemistry and Molecular Biology. 2003 ; Vol. 85, No. 2-5. pp. 457-467.
@article{253e6375f37c42499945f3c540bb6c02,
title = "Tissue glucocorticoid resistance/hypersensitivity syndromes",
abstract = "Glucocorticoids have a broad array of life-sustaining functions and play an important role in the therapy of many diseases. Thus, changes of tissue sensitivity to glucocorticoids may be associated with and influence the course and treatment of many pathologic states. Such tissue sensitivity changes may present on either side of an optimal range, respectively as glucocorticoid resistance or hypersensitivity, and may be generalized or tissue-specific. Familial/sporadic glucocorticoid resistance syndrome caused by inactivating mutations of the glucocorticoid receptor (GR) gene is a classic monogenic disorder associated with congenital, generalized glucocorticoid insensitivity, while several autoimmune, inflammatory and allergic diseases are often associated with resistance of the inflamed tissues to glucocorticoids. On the other hand, glucocorticoid hypersensitivity has been suggested in visceral obesity-related insulin resistance associated with components of the metabolic syndrome, and in the acquired immunodeficiency syndrome (AIDS) caused by human immunodeficiency virus type-1 (HIV-1) infection. Here, we have reviewed the molecular analyses of five familial and three sporadic cases of the familial/sporadic glucocorticoid resistance syndrome and discussed the possible contribution of newly identified molecules, such as HIV-1 accessory proteins Vpr and Tat, FLICE-associated huge protein (FLASH) and chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII), on the molecular regulation of GR activity, as well as their possible contribution to changes in tissue sensitivity to glucocorticoids in pathologic conditions.",
keywords = "Accessory proteins, Glucocorticoid, HIV-1",
author = "Tomoshige Kino and {De Martino}, {Massimo U.} and Evangelia Charmandari and Marco Mirani and Chrousos, {George P.}",
year = "2003",
month = "6",
doi = "10.1016/S0960-0760(03)00218-8",
language = "English",
volume = "85",
pages = "457--467",
journal = "Journal of Steroid Biochemistry and Molecular Biology",
issn = "0960-0760",
publisher = "Elsevier Limited",
number = "2-5",

}

TY - JOUR

T1 - Tissue glucocorticoid resistance/hypersensitivity syndromes

AU - Kino, Tomoshige

AU - De Martino, Massimo U.

AU - Charmandari, Evangelia

AU - Mirani, Marco

AU - Chrousos, George P.

PY - 2003/6

Y1 - 2003/6

N2 - Glucocorticoids have a broad array of life-sustaining functions and play an important role in the therapy of many diseases. Thus, changes of tissue sensitivity to glucocorticoids may be associated with and influence the course and treatment of many pathologic states. Such tissue sensitivity changes may present on either side of an optimal range, respectively as glucocorticoid resistance or hypersensitivity, and may be generalized or tissue-specific. Familial/sporadic glucocorticoid resistance syndrome caused by inactivating mutations of the glucocorticoid receptor (GR) gene is a classic monogenic disorder associated with congenital, generalized glucocorticoid insensitivity, while several autoimmune, inflammatory and allergic diseases are often associated with resistance of the inflamed tissues to glucocorticoids. On the other hand, glucocorticoid hypersensitivity has been suggested in visceral obesity-related insulin resistance associated with components of the metabolic syndrome, and in the acquired immunodeficiency syndrome (AIDS) caused by human immunodeficiency virus type-1 (HIV-1) infection. Here, we have reviewed the molecular analyses of five familial and three sporadic cases of the familial/sporadic glucocorticoid resistance syndrome and discussed the possible contribution of newly identified molecules, such as HIV-1 accessory proteins Vpr and Tat, FLICE-associated huge protein (FLASH) and chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII), on the molecular regulation of GR activity, as well as their possible contribution to changes in tissue sensitivity to glucocorticoids in pathologic conditions.

AB - Glucocorticoids have a broad array of life-sustaining functions and play an important role in the therapy of many diseases. Thus, changes of tissue sensitivity to glucocorticoids may be associated with and influence the course and treatment of many pathologic states. Such tissue sensitivity changes may present on either side of an optimal range, respectively as glucocorticoid resistance or hypersensitivity, and may be generalized or tissue-specific. Familial/sporadic glucocorticoid resistance syndrome caused by inactivating mutations of the glucocorticoid receptor (GR) gene is a classic monogenic disorder associated with congenital, generalized glucocorticoid insensitivity, while several autoimmune, inflammatory and allergic diseases are often associated with resistance of the inflamed tissues to glucocorticoids. On the other hand, glucocorticoid hypersensitivity has been suggested in visceral obesity-related insulin resistance associated with components of the metabolic syndrome, and in the acquired immunodeficiency syndrome (AIDS) caused by human immunodeficiency virus type-1 (HIV-1) infection. Here, we have reviewed the molecular analyses of five familial and three sporadic cases of the familial/sporadic glucocorticoid resistance syndrome and discussed the possible contribution of newly identified molecules, such as HIV-1 accessory proteins Vpr and Tat, FLICE-associated huge protein (FLASH) and chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII), on the molecular regulation of GR activity, as well as their possible contribution to changes in tissue sensitivity to glucocorticoids in pathologic conditions.

KW - Accessory proteins

KW - Glucocorticoid

KW - HIV-1

UR - http://www.scopus.com/inward/record.url?scp=0041386422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041386422&partnerID=8YFLogxK

U2 - 10.1016/S0960-0760(03)00218-8

DO - 10.1016/S0960-0760(03)00218-8

M3 - Article

C2 - 12943736

AN - SCOPUS:0041386422

VL - 85

SP - 457

EP - 467

JO - Journal of Steroid Biochemistry and Molecular Biology

JF - Journal of Steroid Biochemistry and Molecular Biology

SN - 0960-0760

IS - 2-5

ER -